Novartis AG (NVS)

AI Score

Unlock

110.86

1.28 (1.17%)

At close: Apr 17, 2025, 3:59 PM

Novartis AG Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	11.46B	13.39B	7.52B	12.41B	9.66B	11.11B	13.27B	8.86B	7.01B
Short-Term Investments	1.89B	569M	11.41B	15.92B	1.91B	334M	2.69B	625M	770M
Long-Term Investments	1.13B	1.83B	2.55B	3.24B	12.53B	11.16B	10.7B	17.61B	16.5B
Other Long-Term Assets	4.51B	2.18B	1.11B	2.21B	892M	738M	895M	818M	698M
Receivables	9.54B	8.12B	8.94B	8.83B	9.07B	9.17B	9.68B	10.07B	10.2B
Inventory	5.72B	5.91B	7.17B	6.67B	7.13B	5.98B	6.96B	6.87B	6.25B
Other Current Assets	106M	1.25B	2.03B	1.72B	1.98B	2.98B	3.23B	1.03B	n/a
Total Current Assets	29.7B	30.48B	36.91B	45.72B	29.67B	29.5B	35.56B	28.21B	24.93B
Property-Plant & Equipment	10.87B	10.92B	12.2B	13.11B	13.94B	13.75B	15.7B	16.46B	15.64B
Goodwill & Intangibles	51.67B	50.22B	60.95B	63.78B	66.81B	55.31B	74.01B	61.75B	62.32B
Total Long-Term Assets	72.54B	69.46B	80.54B	86.08B	102.39B	88.87B	110B	104.87B	105.19B
Total Assets	102.25B	99.94B	117.45B	131.79B	132.06B	118.37B	145.56B	133.08B	130.12B
Account Payables	4.57B	4.93B	5.15B	5.55B	5.4B	5.42B	5.56B	5.17B	4.87B
Deferred Revenue	127M	98M	123M	123M	56M	114M	236M	305M	287M
Short-Term Debt	8.09B	6.08B	5.93B	6.29B	9.79B	7.03B	9.62B	5.2B	5.91B
Other Current Liabilities	10.13B	10.85B	12.35B	13.29B	12.79B	10.79B	9.63B	8.68B	9.15B
Total Current Liabilities	28.69B	26.39B	28.66B	30.21B	33.06B	28.26B	29.61B	23.4B	22.21B
Long-Term Debt	21.37B	18.44B	20.24B	22.9B	26.26B	20.35B	22.47B	23.22B	17.9B
Other Long-Term Liabilities	4.08B	4.52B	4.91B	4.54B	8.81B	7.08B	8.85B	6.55B	8.03B
Total Long-Term Liabilities	29.43B	26.8B	29.37B	33.77B	42.33B	34.55B	37.26B	35.45B	33.02B
Total Liabilities	58.12B	53.2B	58.03B	63.97B	75.39B	62.82B	66.87B	58.85B	55.23B
Total Debt	31.26B	26.35B	27.96B	31.09B	38.05B	29.33B	32.09B	28.43B	23.8B
Common Stock	793M	825M	890M	901M	913M	936M	944M	969M	972M
Retained Earnings	n/a	49.65B	63.54B	70.99B	57.16B	59.27B	82.19B	77.64B	81.15B
Comprehensive Income	43.31B	-3.77B	58.54B	66.8B	55.74B	54.62B	77.74B	73.3B	73.94B
Shareholders Equity	44.05B	46.67B	59.34B	67.66B	56.6B	55.47B	78.61B	74.17B	74.83B
Total Investments	3.02B	2.4B	11.24B	19.16B	14.44B	11.5B	13.39B	18.24B	17.27B